Breast carcinoma by gene expression profile

Summary

Breast carcinoma by gene expression profile (MONDO:0006116) is a cancer (an umbrella term covering 8 Mondo subtypes). A subtype of breast carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Umbrella term: 8 Mondo subtypes

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	breast carcinoma by gene expression profile
Mondo ID	MONDO:0006116
EFO	EFO:1000143
NCIT	C53553
UMLS	C3642344
MedGen	770984
Is cancer (heuristic)	yes

Also known as: breast carcinoma by gene expression profile

Disease family

This is a subtype of breast carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › breast carcinoma › breast carcinoma by gene expression profile

Related subtypes (12): nipple carcinoma, bilateral breast carcinoma, female breast carcinoma, sporadic breast cancer, breast carcinoma in situ, breast adenocarcinoma, male breast carcinoma, invasive breast carcinoma, Ehrlich tumor carcinoma, hereditary breast carcinoma, cribriform carcinoma of breast, hormone-resistant breast carcinoma

Subtypes (8): progesterone-receptor positive breast cancer, progesterone-receptor negative breast cancer, Her2-receptor negative breast cancer, breast tumor luminal A or B, HER2 positive breast carcinoma, normal breast-like subtype of breast carcinoma, estrogen-receptor positive breast cancer, estrogen-receptor negative breast cancer

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.